Tokyo. – The Japanese University today announced that it has done the first stem cell transplantation induced pluripotency (iPS) to treat malignancy Parkinson,
Transplantation, the first of its kind in the world to treat Parkinson's disease, was carried out last month by the Kyoto University Hospital, an educational center today.
The recipient was a 50-year-old female whose identity was not provided and will be subject to regular checks for two years to prevent rejection.
"We did trepanning on the left side of the head (patient) and transplanted 2.4 million cells," Kyako's vice president Takayuki Kikuchi of Kyoto University said.
The cells used were made using iPS stem cells from donors who have some sort of immunity, which reduces the likelihood of rejection of transplants.
The Parkinson's disease, which means chronic neuronal degeneration, still has no cure. Only in Japan It is estimated that there are 160,000 people with progressive neurological disorders.
March 29, 2017 scientists from General Medical Center in Kobe, in western Japan, announced the first surgical transplant in people with iPS cells in the patient's retina.
A patient with macular degeneration of the retina – an unresponsive eye disorder that could cause blindness – was given a solution injection with retinal cells developed from other iPS from the donor.